Clinical Trial Update: Epunamin Combined With DECP for Relapsed/Refractory Multiple Myeloma

View source ↗

Summary

A clinical trial is evaluating Epunamin in combination with the DECP regimen for relapsed/refractory multiple myeloma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DECP regimen
• Epunamin

Snippet

Sponsor: Shanxi Bethune Hospital | Conditions: Relapsed/Refractory Multiple Myeloma (RRMM), Multiple Myeloma | Status: RECRUITING